These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 35567901)
1. The MAP3K1/c-JUN signaling axis regulates glioblastoma stem cell invasion and tumor progression. Zhou S; Niu R; Sun H; Kim SH; Jin X; Yin J Biochem Biophys Res Commun; 2022 Jul; 612():188-195. PubMed ID: 35567901 [TBL] [Abstract][Full Text] [Related]
2. LncRNA NEAT1 promotes malignant phenotypes and TMZ resistance in glioblastoma stem cells by regulating let-7g-5p/MAP3K1 axis. Bi CL; Liu JF; Zhang MY; Lan S; Yang ZY; Fang JS Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33057597 [TBL] [Abstract][Full Text] [Related]
3. EphA2 promotes infiltrative invasion of glioma stem cells in vivo through cross-talk with Akt and regulates stem cell properties. Miao H; Gale NW; Guo H; Qian J; Petty A; Kaspar J; Murphy AJ; Valenzuela DM; Yancopoulos G; Hambardzumyan D; Lathia JD; Rich JN; Lee J; Wang B Oncogene; 2015 Jan; 34(5):558-67. PubMed ID: 24488013 [TBL] [Abstract][Full Text] [Related]
4. Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells. Iglesia RP; Prado MB; Cruz L; Martins VR; Santos TG; Lopes MH Stem Cell Res Ther; 2017 Apr; 8(1):76. PubMed ID: 28412969 [TBL] [Abstract][Full Text] [Related]
5. Glioblastoma Stem Cell-Derived Exosomes Enhance Stemness and Tumorigenicity of Glioma Cells by Transferring Notch1 Protein. Sun Z; Wang L; Zhou Y; Dong L; Ma W; Lv L; Zhang J; Wang X Cell Mol Neurobiol; 2020 Jul; 40(5):767-784. PubMed ID: 31853695 [TBL] [Abstract][Full Text] [Related]
6. A curcumin derivative hydrazinobenzoylcurcumin suppresses stem-like features of glioblastoma cells by targeting Ca Shin HJ; Lee S; Jung HJ J Cell Biochem; 2019 Apr; 120(4):6741-6752. PubMed ID: 30390339 [TBL] [Abstract][Full Text] [Related]
7. Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo. Signore M; Pelacchi F; di Martino S; Runci D; Biffoni M; Giannetti S; Morgante L; De Majo M; Petricoin EF; Stancato L; Larocca LM; De Maria R; Pallini R; Ricci-Vitiani L Cell Death Dis; 2014 May; 5(5):e1223. PubMed ID: 24810059 [TBL] [Abstract][Full Text] [Related]
8. NFAT1-Mediated Regulation of NDEL1 Promotes Growth and Invasion of Glioma Stem-like Cells. Jiang Y; Song Y; Wang R; Hu T; Zhang D; Wang Z; Tie X; Wang M; Han S Cancer Res; 2019 May; 79(10):2593-2603. PubMed ID: 30940662 [TBL] [Abstract][Full Text] [Related]
9. The mTORC1/mTORC2 inhibitor AZD2014 enhances the radiosensitivity of glioblastoma stem-like cells. Kahn J; Hayman TJ; Jamal M; Rath BH; Kramp T; Camphausen K; Tofilon PJ Neuro Oncol; 2014 Jan; 16(1):29-37. PubMed ID: 24311635 [TBL] [Abstract][Full Text] [Related]
10. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration. Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of the Phospholipase Cε-c-Jun N-Terminal Kinase Axis Suppresses Glioma Stem Cell Properties. Okada M; Nakagawa-Saito Y; Mitobe Y; Sugai A; Togashi K; Suzuki S; Kitanaka C Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955917 [TBL] [Abstract][Full Text] [Related]
12. USF1/CD90 signaling in maintaining glioblastoma stem cells and tumor-associated macrophages adhesion. Zhou Y; Meng X; He W; Li X; Zhao R; Dong C; Yuan D; Yang J; Zhang R; Shi G; Huang Y; Liu J; Liu J; Liu S; Fu P; Sun M Neuro Oncol; 2022 Sep; 24(9):1482-1493. PubMed ID: 35287174 [TBL] [Abstract][Full Text] [Related]
13. Dual Role of CXCL8 in Maintaining the Mesenchymal State of Glioblastoma Stem Cells and M2-Like Tumor-Associated Macrophages. Yuan W; Zhang Q; Gu D; Lu C; Dixit D; Gimple RC; Gao Y; Gao J; Li D; Shan D; Hu L; Li L; Li Y; Ci S; You H; Yan L; Chen K; Zhao N; Xu C; Lan J; Liu D; Zhang J; Shi Z; Wu Q; Yang K; Zhao L; Qiu Z; Lv D; Gao W; Yang H; Lin F; Wang Q; Man J; Li C; Tao W; Agnihotri S; Qian X; Mack SC; Zhang N; You Y; Rich JN; Sun G; Wang X Clin Cancer Res; 2023 Sep; 29(18):3779-3792. PubMed ID: 37439870 [TBL] [Abstract][Full Text] [Related]
14. Wnt/β-catenin signaling is a key downstream mediator of MET signaling in glioblastoma stem cells. Kim KH; Seol HJ; Kim EH; Rheey J; Jin HJ; Lee Y; Joo KM; Lee J; Nam DH Neuro Oncol; 2013 Feb; 15(2):161-71. PubMed ID: 23258844 [TBL] [Abstract][Full Text] [Related]
15. CSNK1D is associated with stemness and invasiveness in glioblastoma. Liu Y; He W; Guo Y; Qu S; Yao F; Liu J; Chai J; Yang Y; Xu T; Liu Y; Yang D; Jia Q; Li M Pathol Res Pract; 2022 Dec; 240():154187. PubMed ID: 36327821 [TBL] [Abstract][Full Text] [Related]
16. Novel function of MDA-9/Syntenin (SDCBP) as a regulator of survival and stemness in glioma stem cells. Talukdar S; Das SK; Pradhan AK; Emdad L; Shen XN; Windle JJ; Sarkar D; Fisher PB Oncotarget; 2016 Aug; 7(34):54102-54119. PubMed ID: 27472461 [TBL] [Abstract][Full Text] [Related]
17. TRIM8 regulates stemness in glioblastoma through PIAS3-STAT3. Zhang C; Mukherjee S; Tucker-Burden C; Ross JL; Chau MJ; Kong J; Brat DJ Mol Oncol; 2017 Mar; 11(3):280-294. PubMed ID: 28100038 [TBL] [Abstract][Full Text] [Related]
18. Targeting atypical protein kinase C iota reduces viability in glioblastoma stem-like cells via a notch signaling mechanism. Phillips E; Lang V; Bohlen J; Bethke F; Puccio L; Tichy D; Herold-Mende C; Hielscher T; Lichter P; Goidts V Int J Cancer; 2016 Oct; 139(8):1776-87. PubMed ID: 27299852 [TBL] [Abstract][Full Text] [Related]
19. REST-DRD2 mechanism impacts glioblastoma stem cell-mediated tumorigenesis. Marisetty AL; Lu L; Veo BL; Liu B; Coarfa C; Kamal MM; Kassem DH; Irshad K; Lu Y; Gumin J; Henry V; Paulucci-Holthauzen A; Rao G; Baladandayuthapani V; Lang FF; Fuller GN; Majumder S Neuro Oncol; 2019 Jun; 21(6):775-785. PubMed ID: 30953587 [TBL] [Abstract][Full Text] [Related]
20. Targeting PDGFRα-activated glioblastoma through specific inhibition of SHP-2-mediated signaling. Sang Y; Hou Y; Cheng R; Zheng L; Alvarez AA; Hu B; Cheng SY; Zhang W; Li Y; Feng H Neuro Oncol; 2019 Nov; 21(11):1423-1435. PubMed ID: 31232447 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]